Cash for CA stem cell co's

Six California stem cell biotech companies received more than $5 million in funding last week from the state's stem cell funding body -- the California Institute for Regenerative Medicine (CIRM), according to a linkurl:news release ;http://www.cirm.ca.gov/pdf/ICOC_121008.pdf from the agency. The money represents the first major pay out to companies from the state's $3 billion research enterprise. Until now, only Novocell Inc. had received a small grant of $50,000. The grants are part of 23 gr

Andrea Gawrylewski
Dec 14, 2008
Six California stem cell biotech companies received more than $5 million in funding last week from the state's stem cell funding body -- the California Institute for Regenerative Medicine (CIRM), according to a linkurl:news release ;http://www.cirm.ca.gov/pdf/ICOC_121008.pdf from the agency. The money represents the first major pay out to companies from the state's $3 billion research enterprise. Until now, only Novocell Inc. had received a small grant of $50,000. The grants are part of 23 grants and nearly $20 million awarded to California institutions for the development of tools and technologies to overcome barriers in stem cell research. Three companies who weren't awarded money filed petitions last week as the
working group was finalizing its granting decisions, complaining that the grant allocations were biased toward academic institutions. CIRM
President Alan Trounson, however, said he could not find "compelling evidence" to change the score of any of the applications, or the decision of the...
a Institute for Regenerative Medicine (CIRM), according to a linkurl:news release ;http://www.cirm.ca.gov/pdf/ICOC_121008.pdf from the agency. The money represents the first major pay out to companies from the state's $3 billion research enterprise. Until now, only Novocell Inc. had received a small grant of $50,000. The grants are part of 23 grants and nearly $20 million awarded to California institutions for the development of tools and technologies to overcome barriers in stem cell research. Three companies who weren't awarded money filed petitions last week as the
working group was finalizing its granting decisions, complaining that the grant allocations were biased toward academic institutions. CIRM
President Alan Trounson, however, said he could not find "compelling evidence" to change the score of any of the applications, or the decision of the CIRM working group that allocates the funding, according to linkurl:The California Stem Cell Report;.http://californiastemcellreport.blogspot.com/
 The companies who won the grants are Novocell, VistaGen Therapeutics, Fluidigm Corp., Gamma-Medica Ideas, Novocell Inc., Invitrogen, and Vala Sciences.
**__Related stories:__***linkurl:Calif. stem cell agency back on track?;http://www.the-scientist.com/news/display/53676/
[4 October 2007]*linkurl:CIRM cuts ten grants;http://www.the-scientist.com/blog/display/53978/
[7 December 2007]*linkurl:CIRM to pay for eggs?;http://www.the-scientist.com/blog/display/54506/
[27 March 2008]

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?